Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
Jérôme Amaudrut, M.A. Argiriadi, Martine Barth et al. · Bioorganic & Medicinal Chemistry Letters · 2019
Cited by 18 works. doi:10.1016/j.bmcl.2019.05.015
Authors
- Jérôme Amaudrut
- M.A. Argiriadi
- Martine Barth
- Eric C. Breinlinger
- Didier Bressac
- Pierre Broqua
- David J. Calderwood
- Mohamed Chatar
- Kevin P. Cusack
- Stephen B. Gauld
- Sébastien Jacquet
- Rajesh V. Kamath
- Michael E. Kort
- Valérie Lepais
- Jean‐Michel Luccarini
- Philippe Masson
- Christian Montalbetti
- Dominique Potin
- Olivia Poupardin
References
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- Structural basis for ligand promiscuity in cytochrome P450 3A4
- Retinoid-Related Orphan Receptors (RORs): Critical Roles in Development, Immunity, Circadian Rhythm, and Cellular Metabolism
- Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field
- The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor-α/γ Inverse Agonist
- Structural Basis for Hydroxycholesterols as Natural Ligands of Orphan Nuclear Receptor RORγ
- IL ‐17‐producing γδ T cells and innate lymphoid cells
- The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases